These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 10213213

  • 1. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 3. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 5. Spatial and temporal expression of angiogenic molecules during tumor growth and progression.
    Kumar R, Kuniyasu H, Bucana CD, Wilson MR, Fidler IJ.
    Oncol Res; 1998 Sep 01; 10(6):301-11. PubMed ID: 9848101
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N, Wion D, Brachet P, Djakiew D.
    J Androl; 2001 Sep 01; 22(3):432-43. PubMed ID: 11330643
    [Abstract] [Full Text] [Related]

  • 7. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep 01; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 8. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 01; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 9. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro.
    Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE.
    Clin Cancer Res; 2000 Nov 01; 6(11):4287-91. PubMed ID: 11106245
    [Abstract] [Full Text] [Related]

  • 10. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2000 May 01; 6(5):2104-19. PubMed ID: 10815938
    [Abstract] [Full Text] [Related]

  • 12. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.
    Clin Cancer Res; 1996 Sep 01; 2(9):1627-36. PubMed ID: 9816342
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
    Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL.
    J Urol; 1997 Jun 01; 157(6):2329-33. PubMed ID: 9146665
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 01; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 15. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B, Ferraro P, Arra C, Baldassarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG, Viglietto G.
    Oncogene; 1999 Aug 26; 18(34):4860-9. PubMed ID: 10490819
    [Abstract] [Full Text] [Related]

  • 16. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ, Treweeke AT, Ke YQ, West DC, Toh CH.
    Br J Cancer; 2000 May 26; 82(10):1694-701. PubMed ID: 10817506
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M.
    Clin Cancer Res; 2000 Feb 26; 6(2):622-30. PubMed ID: 10690548
    [Abstract] [Full Text] [Related]

  • 18. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 01; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.